GlassScriptPhysician profile
Steven A Hemmerdinger
NPI 1174749733
$3,092.62
in general payments reported to CMS, 2019-2025
16 companies · $585 in 2025
The $585 reported for 2025 was more than what a typical Sleep Medicine (Otolaryngology) provider received nationally (typical 2025 total: $509).
See the full distribution for Sleep Medicine (Otolaryngology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $463 · 2021: $293 · 2022: $377 · 2023: $685 · 2024: $278 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.02 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $968.86 | 2019-2025 | |
| Glaxosmithkline, LLC. | $445.14 | 2021-2025 | Nucala |
| Intersect Ent, INC. | $374.84 | 2019-2022 | |
| Depuy Synthes Sales INC. | $351.10 | 2020-2024 | Trumatch |
| Medtronic, INC. | $168.59 | 2022-2024 | Pteye Parathyroid Detection System |
| Regeneron Healthcare Solutions, INC. | $166.88 | 2021-2025 | Dupixent |
| Smith+Nephew, INC. | $137.01 | 2021 | |
| Medical Device Business Services, INC. | $124.99 | 2019 | |
| Optinose US, INC. | $108.65 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2023 | |
| Stryker Corporation | $53.24 | 2020-2021 | |
| Olympus America INC. | $27.96 | 2020 | |
| Inspire Medical Systems, INC. | $24.56 | 2025 | Inspire |
| Alk-Abello, INC | $15.49 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.32 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glenmark Therapeutics INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hemmerdinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.